Parathyroid hormone-dependent signaling pathways regulating genes in bone cells

Gene

Volumn 282, Issue 1-2, 2002, Pages 1-17

  Swarthout, John T ^a   D'Alonzo, Richard C ^a   Selvamurugan, Nagarajan ^b   Partridge, Nicola C ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

G protein; G protein coupled receptor; Gene expression; Osteoblast; Protein kinase A; Protein kinase C

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN; COLLAGEN TYPE 1; COLLAGENASE 3; COLONY STIMULATING FACTOR 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GAP JUNCTION PROTEIN; INTERLEUKIN 6; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEONECTIN; OSTEOPONTIN; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PROTEIN C JUN; PROTEIN KINASE C; RGS PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

BONE CELL; CALCIUM HOMEOSTASIS; CATABOLISM; CELL ACTIVATION; CELL CYCLE; CELL PROLIFERATION; CELL STIMULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; KIDNEY CELL; NONHUMAN; ONCOGENE C FOS; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

NASA DISCIPLINE MUSCULOSKELETAL; NON-NASA CENTER;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; OSTEOBLASTS; PARATHYROID HORMONE; RECEPTORS, PARATHYROID HORMONE; SIGNAL TRANSDUCTION;

EID: 0037045407     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(01)00798-3     Document Type: Review

References (249)

1. Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: A single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium
2. Different bone growth rates are associated with changes in the expression pattern of types II and X collagens and collagenase 3 in proximal growth plates of the rat tibia
3. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
4. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated transacting factor
5. Molecular aspects of tumor cell invasion and metastasis
6. Thrombin and parathyroid hormone mobilize intracellular calcium in rat osteosarcoma cells by distinct pathways
7. Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1
8. Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain
9. Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation
10. Collagenase 2 (MMP-8) expression in murine tissue-remodeling processes. Analysis of its potential role in postpartum involution of the uterus
11. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene
12. Hypercalcemia
13. Primary hyperparathyroidism
14. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage
15. Proteolytic remodeling of extracellular matrix
16. Parathyroid hormone inhibits collagen synthesis and the activity of rat col1a1 transgenes mainly by a cAMP-mediated pathway in mouse calvariae
17. Identification of p90RSK as the probable CREB-Ser133 kinase in human melanocytes
18. Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes
19. Signal transduction and gene control: The cAMP pathway
20. The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats
21. The CREB family of transcription activators
22. Bone collagen synthesis in vitro: Structure/activity relations among parathyroid hormone fragments and analogs
23. Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys
24. Mechanisms underlying the regulation of parathyroid hormone secretion in vivo and in vitro
25. cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor
26. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures
27. The effect of parathyroid hormone on the concentration of adenosine 3′,5′-monophosphate in skeletal tissue in vitro
28. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes
29. PTH elevates inositol polyphosphates and diacylglycerol in a rat osteoblast-like cell line
30. Second messenger signaling in the regulation of collagenase production by osteogenic sarcoma cells
31. Regulation of connexin43 expression and function by prostaglandin E2 (PGE2) and parathyroid hormone (PTH) in osteoblastic cells
32. Parathyroid hormone induces c-fos and c-jun messenger RNA in rat osteoblastic cells
33. How MAP kinases are regulated
34. The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: Transcription factor AP-1 is comprised of multiple protein complexes
35. cAMP-dependent protein kinase, but not the cGMP-dependent enzyme, rapidly phosphorylates delta-CREB, and a synthetic delta-CREB peptide
36. Parathyroid hormone activates mitogen-activated protein kinase in opossum kidney cells
37. Cloning and regulation of rat tissue inhibitor of metalloproteinases-2 in osteoblastic cells
38. Stimulation of osteoblast proliferation by C-terminal fragments of parathyroid hormone-related protein
39. Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence
40. Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits
41. Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation
42. 2+/calmodulin- as well as cAMP-dependent protein kinase
43. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer
44. Multiple and cooperative phosphorylation events regulate the CREM activator function
45. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB
46. Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue
47. Autocrine down-regulation of collagenase-3 in rat bone cell cultures by insulin-like growth factors
48. Anabolic actions of parathyroid hormone on bone
49. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells
50. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats
51. Cyclin D1 and human neoplasia
52. Cyclin E in human cancers
53. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
54. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development
55. The Drosophila segmentation gene runt acts as a position-specific numerator element necessary for the uniform expression of the sex-determining gene Sex-lethal
56. Expression and function of the Drosophila gene runt in early stages of neural development
57. Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle
58. Cell cycle checkpoints: Preventing an identity crisis
59. Toward a molecular understanding of skeletal development
60. The effects of prostaglandin E2, parathyroid hormone, and epidermal growth factor on mitogenesis, signaling, and primary response genes in UMR 106-01 osteoblast-like cells
61. cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells
62. Vitamin D, parathyroid hormone, and calcium: A complex regulatory network
63. Phosphoserine as a recognition determinant for glycogen synthase kinase-3: Phosphorylation of a synthetic peptide based on the G-component of protein phosphatase-1
64. A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression
65. CREB: A mediator of long-term memory from mollusks to mammals
66. Calcium transport in the kidney
67. Dissociation of second messenger activation by parathyroid hormone fragments in osteosarcoma cells
68. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts
69. Phenotypic alterations in Fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression
70. Response of intestinal calcium transport and bone calcium mobilization to 1,25-dihydroxyvitamin D3 in thyroparathyroidectomized rats
71. Mutational analysis of the receptor-activating region of human parathyroid hormone
72. Analysis of parathyroid hormone's principal receptor-binding region by site-directed mutagenesis and analog design
73. Organization and regulation of mitogen-activated protein kinase signaling pathways
74. Skeletal bone morphogenetic proteins suppress the expression of collagenase-3 by rat osteoblasts
75. Endocrine regulation of calcium and phosphate metabolism
76. A PEBP2Alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element
77. Dosage requirements for runt in the segmentation of Drosophila embryos
78. Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock
79. Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA
80. Alignment of U3 region sequences of mammalian type C viruses: Identification of highly conserved motifs and implications for enhancer design
81. Drosophila homologs of the proto-oncogene product PEBP2/CBFβ regulate the DNA-binding properties of Runt
82. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133
83. Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction
84. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling
85. Fos and bone cell development: Lessons from a nuclear oncogene
86. Parathyroid hormone: Biochemical aspects of biosynthesis, secretion, action, and metabolism
87. Stimulation of plasminogen activator in osteoblast-like cells by bone-resorbing hormones
88. Cbfa1 isoforms exert functional differences in osteoblast differentiation
89. q-mediated mitogen-activated protein kinase activation
90. The insulin-like growth factor system and the coupling of formation to resorption
91. Vitamin D: Metabolism and biological actions
92. Characterization of junD: A new member of the jun proto-oncogene family
93. cAMP abrogates the p21ras-mitogen-activated protein kinase pathway in fibroblasts
94. Regulation of the c-fos promoter
95. Signal integration at the c-fos promoter
96. Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription
97. Collagenase from rat uterus. Isolation and partial characterization
98. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
99. Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation
100. Expression of alternatively spliced isoforms of the parathyroid hormone (PTH)/PTH-related peptide receptor messenger RNA in human kidney and bone cells
101. Circulating levels of insulin-like growth factor-I and -II, and IGF-binding protein-3 in inflammation and after parathyroid hormone infusion
102. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development
103. Pleiotropic effects of a null mutation in the c-fos proto-oncogene
104. Further definition of the protein kinase C activation domain of the parathyroid hormone
105. Receptors for parathyroid hormone and parathyroid hormone-related peptide: Exploration of their biological importance
106. The runt domain identifies a new family of heteromeric transcriptional regulators
107. Functional dissection of the α and β subunits of transcription factor PEBP2α and the redox susceptibility of its DNA-binding activity
108. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer
109. The Drosophila segmentation gene runt encodes a novel regulatory protein that is also expressed in the developing nervous system
110. Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit
111. Regulation of Type I Collagen genes' expression in osteoblasts by Cbfa1
112. Biochemical characterization of human collagenase-3
113. Parathyroid hormone versus phorbol ester stimulation of activator protein-1 gene family members in rat osteosarcoma cells
114. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
115. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
116. Parathyroid hormone alters collagen synthesis and procollagen mRNA levels in fetal rat calvaria
117. Parathyroid hormone represses alpha 1(I) collagen promoter activity in cultured calvariae from neonatal transgenic mice
118. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
119. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway
120. Parathyroid hormone stimulates extracellular signal-regulated kinase (ERK) activity through two independent signal transduction pathways: Role of ERK in sodium-phosphate cotransport
121. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: Correlation with osteoclast-like cell formation
122. Transcriptional regulation by CREB and its relatives
123. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements
124. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence
125. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia
126. Functional domains of the t(8;21) fusion protein, AML-1/ETO
127. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis
128. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium
129. Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture
130. Growth factors for bone growth and repair: IGF, TGF beta and BMP
131. Biochemical characterization with parathormone and calcitonin of isolated bone cells: Provisional identification of osteoclasts and osteoblasts
132. Alkaline phosphatase inhibition by parathyroid hormone and isoproterenol in a clonal rat osteosarcoma cell line. Possible mediation by cyclic AMP
133. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis
134. The matrix-degrading metalloproteinases
135. Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation
136. Insulin-like growth factor (IGF) and bone
137. Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures
138. Proto-oncogene c-fos is transcriptionally regulated by parathyroid hormone (PTH) and PTH-related protein in a cyclic adenosine monophosphate-dependent manner in osteoblastic cells
139. Parathyroid hormone stimulates fra-2 expression in osteoblastic cells in vitro and in vivo
140. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines
141. Signal transduction through the cAMP-dependent protein kinase
142. Effects of collagenase-cleavage of type I collagen on α2β1 integrin-mediated cell adhesion
143. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: The runt homology domain is required for DNA binding and protein-protein interactions
144. Dynamic regulation of RGS2 in bone: Potential new insights into parathyroid hormone signaling mechanisms
145. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage
146. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1
147. Transcriptional regulation by cyclic AMP
148. The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: A comparison study between hPTH-(1-34) and hPTH-(1-84)
149. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia
150. Matrix metalloproteinases
151. DNA binding activities of three murine Jun proteins: Stimulation by Fos
152. Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone
153. Cyclic AMP-mediated stabilization of osteocalcin mRNA in rat osteoblast-like cells treated with parathyroid hormone
154. PEBP2/PEA2 represents a new family of transcription factors homologous to the products of the Drosophila runt and the human AML1 gene
155. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila Runt-related DNA-binding protein, PEBP2α
156. Expression of p27Kip1 in osteoblast-like cells during differentiation with parathyroid hormone
157. The mitogenic effect of parathyroid hormone is associated with E2F-dependent activation of cyclin-dependent kinase 1 (cdc2) in osteoblast precursors
158. The carboxy-terminus of parathyroid hormone-inert or invaluable?
159. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
160. The CREB/ATF family of transcription factors: Modulation by reversible phosphorylation
161. Osteoblast proteinases
162. Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells
163. Inhibitory effects of parathyroid hormone on growth of osteogenic sarcoma cells
164. Hormonal regulation of the production of collagenase and a collagenase inhibitor activity by rat osteogenic sarcoma cells
165. Parathyroid hormone inhibits collagen synthesis at both ribonucleic acid and protein levels in rat osteogenic sarcoma cells
166. Collagenase production by normal and malignant osteoblastic cells
167. Signal transduction pathways mediating parathyroid hormone regulation of osteoblastic gene expression
168. The regulation and regulatory role of collagenase in bone
169. Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE
170. Differential regulation of MMP-13 (collagenase-3) and MMP-3 (stromelysin-1) in mouse calvariae
171. Structural analysis and promoter characterization of the human collagenase-3 gene
172. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation
173. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone
174. Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone
175. Structure based design of parathyroid hormone analogs
176. Rat collagenase: Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells
177. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro
178. Fos and Jun bind cooperatively to the AP-1 site: Reconstitution in vitro
179. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: A role in osteoarthritis
180. Parathyroid hormone acutely elevates intracellular calcium in osteoblastlike cells
181. Parathyroid hormone depresses cytosolic pH and DNA synthesis in osteoblast-like cells
182. Cell biology of the osteoclast
183. Clinical review 123: Anabolic therapy for osteoporosis
184. Zebrafish express the common parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R) and a novel receptor (PTH3R) that is preferentially activated by mammalian and fugufish parathyroid hormone-related peptide
185. A G protein-coupled receptor from zebrafish is activated by human parathyroid hormone and not by human or teleost parathyroid hormone-related peptide. Implications for the evolutionary conservation of calcium-regulating peptide hormones
186. c-fos expression induces bone tumors in transgenic mice
187. Mammalian collagenase: Direct demonstration in homogenates of involuting rat uterus
188. c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: Effect of FOS proteins
189. Direct interaction between fos and jun nuclear oncoproteins: Role of the 'leucine zipper' domain
190. Expression of the runt domain-encoding PEBP2α genes in T cells during thymic development
191. Parathyroid hormone up-regulation of connexin 43 gene expression in osteoblasts depends on cell phenotype
192. Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment
193. Parathyroid hormone induces transcription of collagenase in rat osteoblastic cells by a mechanism using cyclic adenosine 3′,5′-monophosphate and requiring protein synthesis
194. Constitutive expression and regulation of collagenase-3 in human breast cancer cells
195. Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence
196. Regulation of collagenase-3 gene expression in osteoblastic and non-osteoblastic cell lines
197. Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha1
198. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals
199. G1 phase progression: Cycling on cue
200. Forskolin inhibits protein kinase C-induced mitogen activated protein kinase activity in MC3T3-E1 osteoblasts
201. CREB and memory
202. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery
203. Expression of runt in the mouse embryo
204. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
205. A small dose of human parathyroid hormone(1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis
206. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis
207. Connexin43 and connexin45 form gap junctions with different molecular permeabilities in osteoblastic cells
208. Proviral insertions induce the expression of bone-specific isoforms of PEBP2αA (CBFA1): Evidence for a new myc collaborating oncogene
209. Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone
210. Expression of parathyroid hormone-related protein in cells of osteoblast lineage
211. 2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity
212. A parathyroid hormone-related protein implicated in malignant hypercalcemia: Cloning and expression
213. Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent
214. Dual signaling and ligand selectivity of the human PTH/PTHrP receptor
215. Bone resorption by osteoclasts
216. Osteonectin, a bone-specific protein linking mineral to collagen
217. Parathyroid hormone induces expression of the nuclear orphan receptor Nurr1 in bone cells
218. Regulation of the nuclear orphan receptor Nur77 in bone by parathyroid hormone
219. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfβ
220. Bovine parathyroid hormone: Minimum chain length of synthetic peptide required for biological activity
221. Expression of the PEBP2αA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells
222. Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cfos-cjun heterodimers
223. Apoptosis mediated by activation of the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein (PTHrP)
224. Increased osteoblastic c-fos expression by parathyroid hormone requires protein kinase A phosphorylation of the cyclic adenosine 3′,5′-monophosphate response element-binding protein at serine 133
225. Parathyroid hormone induction of transcriptional activity of the cAMP response element binding protein requires the serine 129 site and glycogen synthase kinase-3 activity but not casein kinase II sites
226. Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor
227. Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat
228. Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures
229. Parathyroid hormone inhibits mitogen-activated protein kinase activation in osteosarcoma cells via a protein kinase A-dependent pathway
230. Parathyroid hormone activates mitogen-activated protein kinase via a cAMP-mediated pathway independent of Ras
231. Effects of PTH on PTHrP gene expression in human osteoblasts: Up-regulation with the kinetics of an immediate early gene
232. Bone and haematopoietic defects in mice lacking c-fos
233. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor
234. Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase
235. Apoptosis and osteoporosis
236. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein
237. Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis
238. Identification of a new murine runt domain-containing gene, Cbf3a, and localization of the human homolog, CBF3A, to chromosome 1p35-pter
239. Developmental regulation of collagenase-3 mRNA in normal, differentiating osteoblasts through the activator protein-1 and the runt domain binding sites
240. Role of metalloproteinases in human osteoarthritis
241. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
242. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1
243. Coupling of the ras-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase
244. Parathyroid hormone-activated calcium channels in an osteoblast-like clonal osteosarcoma cell line. cAMP-dependent and cAMP-independent calcium channels
245. Protein kinase C-activated calcium channel in the osteoblast-like clonal osteosarcoma cell line UMR-106
246. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB
247. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
248. The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity
249. Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization